On April 5th, Johnson&Johnson and Shockwave Medical announced a final agreement to acquire all outstanding shares of Shockwave in cash at a price of $335 per share. The total value of this transaction is approximately 13.1 billion US dollars, including acquisition cash. The transaction has been approved by the boards of directors of both companies.